SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-18-000031
Filing Date
2018-07-26
Accepted
2018-07-26 16:53:38
Documents
45
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptie-20180630x10q.htm 10-Q 1339618
2 EX-31.1 ptie-20180630xex31_1.htm EX-31.1 25430
3 EX-32.1 ptie-20180630xex32_1.htm EX-32.1 16966
  Complete submission text file 0001069530-18-000031.txt   4639322

Data Files

Seq Description Document Type Size
4 EX-101.INS ptie-20180630.xml EX-101.INS 1140759
5 EX-101.SCH ptie-20180630.xsd EX-101.SCH 24778
6 EX-101.CAL ptie-20180630_cal.xml EX-101.CAL 35221
7 EX-101.DEF ptie-20180630_def.xml EX-101.DEF 71931
8 EX-101.LAB ptie-20180630_lab.xml EX-101.LAB 190591
9 EX-101.PRE ptie-20180630_pre.xml EX-101.PRE 163791
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
PAIN THERAPEUTICS INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 18972311
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1